In May, Britain’s Financial Services Authority acknowledged it was investigating former Dorsey corporate partner Andrew Rimmington and former McDermott corporate partner Michael McFall on insider trading allegations related to Swiss pharmaceutical giant Novartis’s $589 million acquisition of Manchester-based NeuTec Pharma in June 2006.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]